FTC Commissioner Urges Generic Firms To Shun Reverse Payment Deals

The generic industry should refrain from entering into settlement agreements with brand companies that involve payments to keep generics off the market, Federal Trade Commissioner Jon Leibowitz said at the Generic Pharmaceutical Association's Annual Policy Conference in Washington, D.C. Sept. 19